Reduced 5-FU clearance in a patient with low DPD activity due to heterozygosity for a mutant allele of the DPYD gene | British Journal of Cancer
Cost Implications of Reactive Versus Prospective Testing for Dihydropyrimidine Dehydrogenase Deficiency in Patients With Colorectal Cancer: A Single-Institution Experience - Con Murphy, Stephen Byrne, Gul Ahmed, Andrew Kenny, James Gallagher, Harry Harvey,
Dihydropyrimidine Dehydrogenase - an overview | ScienceDirect Topics
Pharmaceutics | Free Full-Text | DPYD and Fluorouracil-Based Chemotherapy: Mini Review and Case Report
Dihydropyrimidine dehydrogenase (DPD) polymorphisms knocking on the door - ecancer
%20gene%20mutation.webp "Dihydropyrimidine Dehydrogenase (DPD) Gene Mutation Test in Delhi | GDIC")
Dihydropyrimidine Dehydrogenase (DPD) Gene Mutation Test in Delhi | GDIC
Figure 1 from Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared
Dihydrofluorouracil - an overview | ScienceDirect Topics
Regulation of human dihydropyrimidine dehydrogenase: implications in the pharmacogenetics of 5-FU-based chemotherapy | Pharmacogenomics
Genome sequencing reveals a novel genetic mechanism underlying dihydropyrimidine dehydrogenase deficiency: A novel missense variant c.1700G>A and a large intragenic inversion in DPYD spanning intron 8 to intron 12 - Kuilenburg -
Cancers | Free Full-Text | Testing for Dihydropyrimidine Dehydrogenase Deficiency to Individualize 5-Fluorouracil Therapy
Dihydropyrimidine dehydrogenase deficiency: MedlinePlus Genetics
DPD Biomarker | Colorectal Cancer Alliance
Pivotal role of dihydropyrimidine dehydrogenase (DPD) in the... | Download Scientific Diagram
Treating patients with dihydropyrimidine dehydrogenase (DPD) deficiency with fluoropyrimidine chemotherapy since the onset of routine prospective testing—The experience of a large oncology center in the United Kingdom - ScienceDirect
Evolution of Dihydropyrimidine Dehydrogenase Diagnostic Testing in a Single Center during an 8-Year Period of Time - ScienceDirect
DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update - Annals of Oncology
Capecitabine-Induced Severe Toxicity Secondary to DPD Deficiency and Successful Treatment with Low Dose 5-Fluorouracil | SpringerLink
DPD Gene Mutations (5-FU toxicity) detection test in Alwar
Dihydropyrimidine Dehydrogenase Deficiency - an overview | ScienceDirect Topics
Schematic representation of the DPD gene structure and polymorphism | Download Scientific Diagram
Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity | Pharmacogenomics
DPD Biomarker | Colorectal Cancer Alliance
DPD Deficiency Foundation | Grafton MA
TRUPCR® DPYD Mutation Detection Kit | TRUPCR Europe
Ethnic Diversity of DPD activity and the DPYD Gene | PGPM
Issues and limitations of available biomarkers for fluoropyrimidine-based chemotherapy toxicity, a narrative review of the literature - ESMO Open
